Lumen announced today top-line results from the sentinel cohort of its RePreve Clinical Trial evaluating LMN-201 for Clostridioides difficile infection (CDI). C. difficile infection sustained ...

Clostridium difficile, also known as C. diff, is a bacteria that spreads easily, is 'immune' to disinfectants and kills about six percent of people it infects — mostly older adults. Previous ...

About LMN-201 and Lumen Bio LMN-201 is orally delivered (capsules; no enema or "bowel cleanse" required) and highly scalable, allowing for much broader potential use in routine CDI management.

These include inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and chronic constipation. There are also isolated reports of FMT effects in nongastrointestinal disease, including ...

[35] Intestinal barrier is a functional entity separating the gut lumen from the inner host, and consisting of mechanical elements (mucus, epithelial layer), humoral elements (defensins ...

difficile bacteria. Acetate is a short-chain fatty acid produced by the digestion of soluble fibers, a process carried out by the bacteria that live in the intestine. In the study, mice fed a ...

difficile bacteria. Acetate is a short-chain fatty acid produced by the digestion of soluble fibers, a process carried out by the bacteria that live in the intestine. In the study, mice fed a low ...

When your body is healthy, it maintains pH balance on its own. However, certain health conditions can cause pH imbalances, which make it difficult for your body to function properly. Sometimes ...